Healthcare provider profile · identity verified

Diego Hernando Remolina, MD

Geriatric Medicine · ATLANTA, GA · NPI 1952557977

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	687	220
Amlodipine Besylate	Amlodipine Besylate	612	188
Levothyroxine Sodium	Levothyroxine Sodium	444	121
Lisinopril	Lisinopril	331	88
Sertraline Hcl	Sertraline Hcl	321	89
Losartan Potassium	Losartan Potassium	288	89
Pantoprazole Sodium	Pantoprazole Sodium	261	76
Metoprolol Succinate	Metoprolol Succinate	243	60
Gabapentin	Gabapentin	230	79
Simvastatin	Simvastatin	219	62
Tamsulosin Hcl	Tamsulosin Hcl	191	59
Escitalopram Oxalate	Escitalopram Oxalate	186	57
Hydrochlorothiazide	Hydrochlorothiazide	186	58
Rosuvastatin Calcium	Rosuvastatin Calcium	183	64
Eliquis	Apixaban	173	50
Donepezil Hcl	Donepezil Hcl	164	47
Pravastatin Sodium	Pravastatin Sodium	164	42
Metformin Hcl	Metformin Hcl	161	55
Omeprazole	Omeprazole	160	44
Furosemide	Furosemide	155	41
Carvedilol	Carvedilol	128	34
Trazodone Hcl	Trazodone Hcl	118	37
Famotidine	Famotidine	114	39
Memantine Hcl	Memantine Hcl	111	28
Metoprolol Tartrate	Metoprolol Tartrate	108	24
Mirtazapine	Mirtazapine	101	25
Allopurinol	Allopurinol	97	27
Potassium Chloride	Potassium Chloride	97	31
Fluticasone Propionate	Fluticasone Propionate	89	49
Montelukast Sodium	Montelukast Sodium	89	16
Albuterol Sulfate Hfa	Albuterol Sulfate	83	26
Alendronate Sodium	Alendronate Sodium	79	22
Duloxetine Hcl	Duloxetine Hcl	71	25
Spironolactone	Spironolactone	68	20
Quetiapine Fumarate	Quetiapine Fumarate	66	14
Risperidone	Risperidone	64	suppressed
Myrbetriq	Mirabegron	60	14
Valsartan	Valsartan	59	17
Finasteride	Finasteride	58	20
Tramadol Hcl	Tramadol Hcl	55	17
Metformin Hcl Er	Metformin Hcl	54	19
Nifedipine Er	Nifedipine	54	17
Zolpidem Tartrate	Zolpidem Tartrate	54	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	51	14
Hydralazine Hcl	Hydralazine Hcl	50	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	12
Clopidogrel	Clopidogrel Bisulfate	47	18
Synthroid	Levothyroxine Sodium	47	14
Atenolol	Atenolol	46	12
Citalopram Hbr	Citalopram Hydrobromide	46	18
Tradjenta	Linagliptin	45	suppressed
Bupropion Xl	Bupropion Hcl	41	13
Fluoxetine Hcl	Fluoxetine Hcl	41	15
Januvia	Sitagliptin Phosphate	41	13
Diclofenac Sodium	Diclofenac Sodium	38	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	13
Memantine Hcl Er	Memantine Hcl	35	suppressed
Alprazolam	Alprazolam	34	suppressed
Glimepiride	Glimepiride	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Verapamil Er	Verapamil Hcl	30	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Jardiance	Empagliflozin	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	26	25
Torsemide	Torsemide	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	21
Pregabalin	Pregabalin	25	13
Chlorthalidone	Chlorthalidone	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Labetalol Hcl	Labetalol Hcl	22	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Ramipril	Ramipril	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Lovastatin	Lovastatin	18	suppressed
Primidone	Primidone	18	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Ozempic	Semaglutide	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Glipizide	Glipizide	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Methimazole	Methimazole	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Calcitriol	Calcitriol	15	suppressed
Clonidine	Clonidine	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Estradiol	Estradiol	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Rytary	Carbidopa/Levodopa	15	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Hydroxyurea	Hydroxyurea	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error